<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2001-12-05" modified="2020-10-07" version="194">
<accession>Q9UQF2</accession>
<accession>D3DQP4</accession>
<accession>O43407</accession>
<name>JIP1_HUMAN</name>
<protein>
<recommendedName>
<fullName>C-Jun-amino-terminal kinase-interacting protein 1</fullName>
<shortName>JIP-1</shortName>
<shortName>JNK-interacting protein 1</shortName>
</recommendedName>
<alternativeName>
<fullName>Islet-brain 1</fullName>
<shortName>IB-1</shortName>
</alternativeName>
<alternativeName>
<fullName>JNK MAP kinase scaffold protein 1</fullName>
</alternativeName>
<alternativeName>
<fullName>Mitogen-activated protein kinase 8-interacting protein 1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">MAPK8IP1</name>
<name type="synonym">IB1</name>
<name type="synonym">JIP1</name>
<name type="synonym">PRKM8IP</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1999" name="Genomics" volume="55" first="202" last="208">
<title>Genomic organization, fine-mapping, and expression of the human islet-brain 1 (IB1)/C-jun-amino-terminal kinase interacting protein-1 (JIP-1) gene.</title>
<authorList>
<person name="Mooser V."/>
<person name="Maillard A."/>
<person name="Bonny C."/>
<person name="Steinmann M."/>
<person name="Shaw P."/>
<person name="Yarnall D.P."/>
<person name="Burns D.K."/>
<person name="Schorderet D.F."/>
<person name="Nicod P."/>
<person name="Waeber G."/>
</authorList>
<dbReference type="PubMed" id="9933567"/>
<dbReference type="DOI" id="10.1006/geno.1998.5641"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Insulinoma</tissue>
</source>
</reference>
<reference key="2">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="submission" date="1997-06" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Yu W."/>
<person name="Sarginson J."/>
<person name="Gibbs R.A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 468-711</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="35113" last="35118">
<title>Interaction of c-Jun amino-terminal kinase interacting protein-1 with p190 rhoGEF and its localization in differentiated neurons.</title>
<authorList>
<person name="Meyer D."/>
<person name="Liu A."/>
<person name="Margolis B."/>
</authorList>
<dbReference type="PubMed" id="10574993"/>
<dbReference type="DOI" id="10.1074/jbc.274.49.35113"/>
</citation>
<scope>INTERACTION WITH ARHGEF28</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2001" name="J. Cell Biol." volume="152" first="959" last="970">
<title>Cargo of kinesin identified as JIP scaffolding proteins and associated signaling molecules.</title>
<authorList>
<person name="Verhey K.J."/>
<person name="Meyer D."/>
<person name="Deehan R."/>
<person name="Blenis J."/>
<person name="Schnapp B.J."/>
<person name="Rapoport T.A."/>
<person name="Margolis B."/>
</authorList>
<dbReference type="PubMed" id="11238452"/>
<dbReference type="DOI" id="10.1083/jcb.152.5.959"/>
</citation>
<scope>MUTAGENESIS</scope>
<scope>INTERACTION WITH KINESIN</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2001" name="J. Biochem." volume="130" first="773" last="781">
<title>Mixed lineage kinase LZK forms a functional signaling complex with JIP-1, a scaffold protein of the c-Jun NH(2)-terminal kinase pathway.</title>
<authorList>
<person name="Ikeda A."/>
<person name="Hasegawa K."/>
<person name="Masaki M."/>
<person name="Moriguchi T."/>
<person name="Nishida E."/>
<person name="Kozutsumi Y."/>
<person name="Oka S."/>
<person name="Kawasaki T."/>
</authorList>
<dbReference type="PubMed" id="11726277"/>
<dbReference type="DOI" id="10.1093/oxfordjournals.jbchem.a003048"/>
</citation>
<scope>INTERACTION WITH MAP3K13</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="20070" last="20078">
<title>Interaction of Alzheimer's beta-amyloid precursor family proteins with scaffold proteins of the JNK signaling cascade.</title>
<authorList>
<person name="Taru H."/>
<person name="Iijima K."/>
<person name="Hase M."/>
<person name="Kirino Y."/>
<person name="Yagi Y."/>
<person name="Suzuki T."/>
</authorList>
<dbReference type="PubMed" id="11912189"/>
<dbReference type="DOI" id="10.1074/jbc.m108372200"/>
</citation>
<scope>INTERACTION WITH APP</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="28694" last="28702">
<title>Recruitment of JNK to JIP1 and JNK-dependent JIP1 phosphorylation regulates JNK module dynamics and activation.</title>
<authorList>
<person name="Nihalani D."/>
<person name="Wong H.N."/>
<person name="Holzman L.B."/>
</authorList>
<dbReference type="PubMed" id="12756254"/>
<dbReference type="DOI" id="10.1074/jbc.m304212200"/>
</citation>
<scope>PHOSPHORYLATION AT THR-103 AND THR-205</scope>
<scope>MUTAGENESIS OF ARG-160 AND PRO-161</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2001" name="Diabetes" volume="50" first="77" last="82">
<title>Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death.</title>
<authorList>
<person name="Bonny C."/>
<person name="Oberson A."/>
<person name="Negri S."/>
<person name="Sauser C."/>
<person name="Schorderet D.F."/>
</authorList>
<dbReference type="PubMed" id="11147798"/>
<dbReference type="DOI" id="10.2337/diabetes.50.1.77"/>
</citation>
<scope>PEPTIDE INHIBITORS OF JNK</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="48720" last="48726">
<title>Calcium- and proteasome-dependent degradation of the JNK scaffold protein islet-brain 1.</title>
<authorList>
<person name="Allaman-Pillet N."/>
<person name="Storling J."/>
<person name="Oberson A."/>
<person name="Roduit R."/>
<person name="Negri S."/>
<person name="Sauser C."/>
<person name="Nicod P."/>
<person name="Beckmann J.S."/>
<person name="Schorderet D.F."/>
<person name="Mandrup-Poulsen T."/>
<person name="Bonny C."/>
</authorList>
<dbReference type="PubMed" id="14507925"/>
<dbReference type="DOI" id="10.1074/jbc.m306745200"/>
</citation>
<scope>CALCIUM- AND PROTEASOME-DEPENDENT DEGRADATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2003" name="Nat. Med." volume="9" first="1180" last="1186">
<title>A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia.</title>
<authorList>
<person name="Borsello T."/>
<person name="Clarke P.G."/>
<person name="Hirt L."/>
<person name="Vercelli A."/>
<person name="Repici M."/>
<person name="Schorderet D.F."/>
<person name="Bogousslavsky J."/>
<person name="Bonny C."/>
</authorList>
<dbReference type="PubMed" id="12937412"/>
<dbReference type="DOI" id="10.1038/nm911"/>
</citation>
<scope>PROTECTION AGAINST EXCITOTOXICITY AND CEREBRAL ISCHEMIA</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2006" name="Mol. Cell. Proteomics" volume="5" first="97" last="113">
<title>Hyperphosphorylation of JNK-interacting protein 1, a protein associated with Alzheimer disease.</title>
<authorList>
<person name="D'Ambrosio C."/>
<person name="Arena S."/>
<person name="Fulcoli G."/>
<person name="Scheinfeld M.H."/>
<person name="Zhou D."/>
<person name="D'Adamio L."/>
<person name="Scaloni A."/>
</authorList>
<dbReference type="PubMed" id="16195223"/>
<dbReference type="DOI" id="10.1074/mcp.m500226-mcp200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-40; SER-152; SER-181; SER-187; SER-193; SER-195; SER-196; SER-214; SER-311; SER-328; SER-330; SER-340; SER-355; SER-366; SER-369; SER-407; SER-409; THR-411; SER-444; SER-447; THR-448; SER-469; SER-471; SER-472 AND SER-473</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2007" name="Mol. Cell. Biol." volume="27" first="7273" last="7283">
<title>Vaccinia-related kinase 2 modulates the stress response to hypoxia mediated by TAK1.</title>
<authorList>
<person name="Blanco S."/>
<person name="Santos C."/>
<person name="Lazo P.A."/>
</authorList>
<dbReference type="PubMed" id="17709393"/>
<dbReference type="DOI" id="10.1128/mcb.00025-07"/>
</citation>
<scope>INTERACTION WITH MAP3K7</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2008" name="PLoS ONE" volume="3" first="E1660" last="E1660">
<title>Modulation of interleukin-1 transcriptional response by the interaction between VRK2 and the JIP1 scaffold protein.</title>
<authorList>
<person name="Blanco S."/>
<person name="Sanz-Garcia M."/>
<person name="Santos C.R."/>
<person name="Lazo P.A."/>
</authorList>
<dbReference type="PubMed" id="18286207"/>
<dbReference type="DOI" id="10.1371/journal.pone.0001660"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH VRK2</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2000" name="Nat. Genet." volume="24" first="291" last="295">
<title>The gene, MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes.</title>
<authorList>
<person name="Waeber G."/>
<person name="Delplanque J."/>
<person name="Bonny C."/>
<person name="Mooser V."/>
<person name="Steinmann M."/>
<person name="Widmann C."/>
<person name="Maillard A."/>
<person name="Miklossy J."/>
<person name="Dina C."/>
<person name="Hani E.H."/>
<person name="Vionnet N."/>
<person name="Nicod P."/>
<person name="Boutin P."/>
<person name="Froguel P."/>
</authorList>
<dbReference type="PubMed" id="10700186"/>
<dbReference type="DOI" id="10.1038/73523"/>
</citation>
<scope>VARIANT NIDDM ASN-59</scope>
</reference>
<comment type="function">
<text evidence="3">The JNK-interacting protein (JIP) group of scaffold proteins selectively mediates JNK signaling by aggregating specific components of the MAPK cascade to form a functional JNK signaling module. Required for JNK activation in response to excitotoxic stress. Cytoplasmic MAPK8IP1 causes inhibition of JNK-regulated activity by retaining JNK in the cytoplasm and inhibiting JNK phosphorylation of c-Jun. May also participate in ApoER2-specific reelin signaling. Directly, or indirectly, regulates GLUT2 gene expression and beta-cell function. Appears to have a role in cell signaling in mature and developing nerve terminals. May function as a regulator of vesicle transport, through interactions with the JNK-signaling components and motor proteins. Functions as an anti-apoptotic protein and whose level seems to influence the beta-cell death or survival response. Acts as a scaffold protein that coordinates with SH3RF1 in organizing different components of the JNK pathway, including RAC1 or RAC2, MAP3K11/MLK3 or MAP3K7/TAK1, MAP2K7/MKK7, MAPK8/JNK1 and/or MAPK9/JNK2 into a functional multiprotein complex to ensure the effective activation of the JNK signaling pathway. Regulates the activation of MAPK8/JNK1 and differentiation of CD8(+) T-cells.</text>
</comment>
<comment type="subunit">
<text evidence="2 3 6 8 9 10 13 14">Forms homo- or heterooligomeric complexes. Binds specific components of the JNK signaling pathway namely, MAPK8/JNK1, MAPK9/JNK2, MAPK10/JNK3, MAP2K7/MKK7, MAP3K11/MLK3 and DLK1. Also binds the proline-rich domain-containing splice variant of apolipoprotein E receptor 2 (ApoER2). Interacts, via the PID domain, with ARHGEF28. Binds the cytoplasmic tails of LRP1 and LRP2 (Megalin). Binds the TPR motif-containing C-terminal of KNS2, then the pre-assembled MAPK8IP1 scaffolding complexes are transported as a cargo of kinesin, to the required subcellular location. Interacts with the cytoplasmic domain of APP. Interacts with DCLK2 (By similarity). Interacts with MAP3K7/TAK1. Interacts with isoform 1 and isoform 2 of VRK2. Found in a complex with SH3RF1, RAC1, MAP3K11/MLK3, MAP2K7/MKK7 and MAPK8/JNK1. Found in a complex with SH3RF1, RAC2, MAP3K7/TAK1, MAP2K7/MKK7, MAPK8/JNK1 and MAPK9/JNK2. Interacts with SH3RF2 (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78404">
<id>Q9UQF2</id>
</interactant>
<interactant intactId="EBI-297353">
<id>P00533</id>
<label>EGFR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78404">
<id>Q9UQF2</id>
</interactant>
<interactant intactId="EBI-641062">
<id>P04626</id>
<label>ERBB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78404">
<id>Q9UQF2</id>
</interactant>
<interactant intactId="EBI-492605">
<id>O14733</id>
<label>MAP2K7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78404">
<id>Q9UQF2</id>
</interactant>
<interactant intactId="EBI-358684">
<id>O43318</id>
<label>MAP3K7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78404">
<id>Q9UQF2</id>
</interactant>
<interactant intactId="EBI-286483">
<id>P45983</id>
<label>MAPK8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78404">
<id>Q9UQF2</id>
</interactant>
<interactant intactId="EBI-78814">
<id>P12023</id>
<label>App</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="1">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="1">Cytoplasm</location>
<location evidence="1">Perinuclear region</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="1">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Endoplasmic reticulum membrane</location>
</subcellularLocation>
<subcellularLocation>
<location>Mitochondrion membrane</location>
</subcellularLocation>
<text evidence="1">Accumulates in cell surface projections. Under certain stress conditions, translocates to the perinuclear region of neurons. In insulin-secreting cells, detected in both the cytoplasm and nucleus (By similarity).</text>
</comment>
<comment type="tissue specificity">
<text>Highly expressed in brain. Expressed in neurons, localizing to neurite tips in differentiating cells. Also expressed in the pancreas, testis and prostate. Low levels in heart, ovary and small intestine. Decreased levels in pancreatic beta cells sensitize cells to IL-1-beta-induced apoptosis.</text>
</comment>
<comment type="domain">
<text>The destruction boxes (D-box) may act as recognition signals for degradation via the ubiquitin-proteasome pathway.</text>
</comment>
<comment type="domain">
<text>A minimal inhibitory domain prevents pancreatic beta cell apoptosis in vitro, and prevents activation of c-jun by MAPK8, MAPK9 and MAPK10.</text>
</comment>
<comment type="domain">
<text evidence="1">The SH3 domain mediates homodimerization.</text>
</comment>
<comment type="PTM">
<text evidence="11">Phosphorylated by MAPK8, MAPK9 and MAPK10. Phosphorylation on Thr-103 is also necessary for the dissociation and activation of MAP3K12. Phosphorylated by isoform 1 and isoform 2 of VRK2. Hyperphosphorylated during mitosis following activation of stress-activated and MAP kinases.</text>
</comment>
<comment type="PTM">
<text>Ubiquitinated. Two preliminary events are required to prime for ubiquitination; phosphorylation and an increased in intracellular calcium concentration. Then, the calcium influx initiates ubiquitination and degradation by the ubiquitin-proteasome pathway.</text>
</comment>
<comment type="disease" evidence="7">
<disease id="DI-02060">
<name>Diabetes mellitus, non-insulin-dependent</name>
<acronym>NIDDM</acronym>
<description>A multifactorial disorder of glucose homeostasis caused by a lack of sensitivity to the body's own insulin. Affected individuals usually have an obese body habitus and manifestations of a metabolic syndrome characterized by diabetes, insulin resistance, hypertension and hypertriglyceridemia. The disease results in long-term complications that affect the eyes, kidneys, nerves, and blood vessels.</description>
<dbReference type="MIM" id="125853"/>
</disease>
<text>The disease may be caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text>A chemically synthesized cell-permeable peptide of the minimal inhibitory domain decreases brain lesions in both transient and permanent ischemia. The level of protection is still high when administered 6 or 12 hours after ischemia.</text>
</comment>
<comment type="similarity">
<text evidence="15">Belongs to the JIP scaffold family.</text>
</comment>
<dbReference type="EMBL" id="AF074091">
<property type="protein sequence ID" value="AAD20443.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471064">
<property type="protein sequence ID" value="EAW68027.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471064">
<property type="protein sequence ID" value="EAW68028.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF007134">
<property type="protein sequence ID" value="AAC19150.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS7916.1"/>
<dbReference type="RefSeq" id="NP_005447.1">
<property type="nucleotide sequence ID" value="NM_005456.3"/>
</dbReference>
<dbReference type="PDB" id="2G01">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="F/G=157-167"/>
</dbReference>
<dbReference type="PDB" id="2GMX">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="F/G=157-167"/>
</dbReference>
<dbReference type="PDB" id="2H96">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="F/G=157-167"/>
</dbReference>
<dbReference type="PDB" id="3OXI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="J=158-167"/>
</dbReference>
<dbReference type="PDB" id="3PTG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.43"/>
<property type="chains" value="J=157-167"/>
</dbReference>
<dbReference type="PDB" id="3VUD">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="F=157-167"/>
</dbReference>
<dbReference type="PDB" id="3VUG">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.24"/>
<property type="chains" value="F=157-167"/>
</dbReference>
<dbReference type="PDB" id="3VUH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="F=157-167"/>
</dbReference>
<dbReference type="PDB" id="3VUI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="F=157-167"/>
</dbReference>
<dbReference type="PDB" id="3VUK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.95"/>
<property type="chains" value="F=157-167"/>
</dbReference>
<dbReference type="PDB" id="3VUL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.81"/>
<property type="chains" value="F=157-167"/>
</dbReference>
<dbReference type="PDB" id="3VUM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.69"/>
<property type="chains" value="F=157-167"/>
</dbReference>
<dbReference type="PDB" id="4E73">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.27"/>
<property type="chains" value="B=158-167"/>
</dbReference>
<dbReference type="PDB" id="4G1W">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.45"/>
<property type="chains" value="B=157-167"/>
</dbReference>
<dbReference type="PDB" id="4H39">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.99"/>
<property type="chains" value="B=158-167"/>
</dbReference>
<dbReference type="PDB" id="4HYS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.42"/>
<property type="chains" value="B=157-167"/>
</dbReference>
<dbReference type="PDB" id="4HYU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.15"/>
<property type="chains" value="B=157-167"/>
</dbReference>
<dbReference type="PDB" id="4IZY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="B=157-167"/>
</dbReference>
<dbReference type="PDB" id="5LW1">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="C/F/I=157-167"/>
</dbReference>
<dbReference type="PDB" id="6FUZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=701-711"/>
</dbReference>
<dbReference type="PDBsum" id="2G01"/>
<dbReference type="PDBsum" id="2GMX"/>
<dbReference type="PDBsum" id="2H96"/>
<dbReference type="PDBsum" id="3OXI"/>
<dbReference type="PDBsum" id="3PTG"/>
<dbReference type="PDBsum" id="3VUD"/>
<dbReference type="PDBsum" id="3VUG"/>
<dbReference type="PDBsum" id="3VUH"/>
<dbReference type="PDBsum" id="3VUI"/>
<dbReference type="PDBsum" id="3VUK"/>
<dbReference type="PDBsum" id="3VUL"/>
<dbReference type="PDBsum" id="3VUM"/>
<dbReference type="PDBsum" id="4E73"/>
<dbReference type="PDBsum" id="4G1W"/>
<dbReference type="PDBsum" id="4H39"/>
<dbReference type="PDBsum" id="4HYS"/>
<dbReference type="PDBsum" id="4HYU"/>
<dbReference type="PDBsum" id="4IZY"/>
<dbReference type="PDBsum" id="5LW1"/>
<dbReference type="PDBsum" id="6FUZ"/>
<dbReference type="SMR" id="Q9UQF2"/>
<dbReference type="BioGRID" id="114864">
<property type="interactions" value="40"/>
</dbReference>
<dbReference type="CORUM" id="Q9UQF2"/>
<dbReference type="ELM" id="Q9UQF2"/>
<dbReference type="IntAct" id="Q9UQF2">
<property type="interactions" value="26"/>
</dbReference>
<dbReference type="MINT" id="Q9UQF2"/>
<dbReference type="STRING" id="9606.ENSP00000241014"/>
<dbReference type="DrugBank" id="DB07276">
<property type="generic name" value="5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE"/>
</dbReference>
<dbReference type="DrugBank" id="DB07218">
<property type="generic name" value="6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE"/>
</dbReference>
<dbReference type="DrugBank" id="DB11157">
<property type="generic name" value="Anthralin"/>
</dbReference>
<dbReference type="DrugBank" id="DB07272">
<property type="generic name" value="N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE"/>
</dbReference>
<dbReference type="DrugBank" id="DB01782">
<property type="generic name" value="Pyrazolanthrone"/>
</dbReference>
<dbReference type="iPTMnet" id="Q9UQF2"/>
<dbReference type="PhosphoSitePlus" id="Q9UQF2"/>
<dbReference type="BioMuta" id="MAPK8IP1"/>
<dbReference type="DMDM" id="17433093"/>
<dbReference type="MassIVE" id="Q9UQF2"/>
<dbReference type="PaxDb" id="Q9UQF2"/>
<dbReference type="PeptideAtlas" id="Q9UQF2"/>
<dbReference type="PRIDE" id="Q9UQF2"/>
<dbReference type="ProteomicsDB" id="85551"/>
<dbReference type="Antibodypedia" id="26197">
<property type="antibodies" value="261 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000241014">
<property type="protein sequence ID" value="ENSP00000241014"/>
<property type="gene ID" value="ENSG00000121653"/>
</dbReference>
<dbReference type="GeneID" id="9479"/>
<dbReference type="KEGG" id="hsa:9479"/>
<dbReference type="UCSC" id="uc001nbr.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="9479"/>
<dbReference type="DisGeNET" id="9479"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000121653.11"/>
<dbReference type="GeneCards" id="MAPK8IP1"/>
<dbReference type="HGNC" id="HGNC:6882">
<property type="gene designation" value="MAPK8IP1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000121653">
<property type="expression patterns" value="Tissue enhanced (brain)"/>
</dbReference>
<dbReference type="MalaCards" id="MAPK8IP1"/>
<dbReference type="MIM" id="125853">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="604641">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9UQF2"/>
<dbReference type="OpenTargets" id="ENSG00000121653"/>
<dbReference type="PharmGKB" id="PA30626"/>
<dbReference type="eggNOG" id="KOG3775">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000157089"/>
<dbReference type="HOGENOM" id="CLU_006711_1_1_1"/>
<dbReference type="InParanoid" id="Q9UQF2"/>
<dbReference type="KO" id="K04434"/>
<dbReference type="OMA" id="QGNKCSH"/>
<dbReference type="OrthoDB" id="372907at2759"/>
<dbReference type="PhylomeDB" id="Q9UQF2"/>
<dbReference type="TreeFam" id="TF325073"/>
<dbReference type="PathwayCommons" id="Q9UQF2"/>
<dbReference type="SignaLink" id="Q9UQF2"/>
<dbReference type="SIGNOR" id="Q9UQF2"/>
<dbReference type="BioGRID-ORCS" id="9479">
<property type="hits" value="6 hits in 877 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="MAPK8IP1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q9UQF2"/>
<dbReference type="GeneWiki" id="MAPK8IP1"/>
<dbReference type="GenomeRNAi" id="9479"/>
<dbReference type="Pharos" id="Q9UQF2">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q9UQF2"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 11"/>
</dbReference>
<dbReference type="RNAct" id="Q9UQF2">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000121653">
<property type="expression patterns" value="Expressed in C1 segment of cervical spinal cord and 138 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q9UQF2">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9UQF2">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0044295">
<property type="term" value="C:axonal growth cone"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0044297">
<property type="term" value="C:cell body"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0044294">
<property type="term" value="C:dendritic growth cone"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0044302">
<property type="term" value="C:dentate gyrus mossy fiber"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005789">
<property type="term" value="C:endoplasmic reticulum membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0031966">
<property type="term" value="C:mitochondrial membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0045202">
<property type="term" value="C:synapse"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008432">
<property type="term" value="F:JUN kinase binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019894">
<property type="term" value="F:kinesin binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005078">
<property type="term" value="F:MAP-kinase scaffold activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031434">
<property type="term" value="F:mitogen-activated protein kinase kinase binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031435">
<property type="term" value="F:mitogen-activated protein kinase kinase kinase binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004860">
<property type="term" value="F:protein kinase inhibitor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007258">
<property type="term" value="P:JUN phosphorylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2001243">
<property type="term" value="P:negative regulation of intrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043508">
<property type="term" value="P:negative regulation of JUN kinase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046330">
<property type="term" value="P:positive regulation of JNK cascade"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000564">
<property type="term" value="P:regulation of CD8-positive, alpha-beta T cell proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046328">
<property type="term" value="P:regulation of JNK cascade"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006355">
<property type="term" value="P:regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016192">
<property type="term" value="P:vesicle-mediated transport"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd11943">
<property type="entry name" value="SH3_JIP1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.30.29.30">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00227"/>
<dbReference type="InterPro" id="IPR035638">
<property type="entry name" value="JIP1_SH3"/>
</dbReference>
<dbReference type="InterPro" id="IPR011993">
<property type="entry name" value="PH-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR006020">
<property type="entry name" value="PTB/PI_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036028">
<property type="entry name" value="SH3-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001452">
<property type="entry name" value="SH3_domain"/>
</dbReference>
<dbReference type="Pfam" id="PF00640">
<property type="entry name" value="PID"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF14604">
<property type="entry name" value="SH3_9"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00462">
<property type="entry name" value="PTB"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00326">
<property type="entry name" value="SH3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF50044">
<property type="entry name" value="SSF50044"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS01179">
<property type="entry name" value="PID"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50002">
<property type="entry name" value="SH3"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0219">Diabetes mellitus</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0256">Endoplasmic reticulum</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0496">Mitochondrion</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0728">SH3 domain</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="C-Jun-amino-terminal kinase-interacting protein 1" id="PRO_0000220628">
<location>
<begin position="1"/>
<end position="711"/>
</location>
</feature>
<feature type="domain" description="SH3" evidence="5">
<location>
<begin position="488"/>
<end position="549"/>
</location>
</feature>
<feature type="domain" description="PID" evidence="4">
<location>
<begin position="561"/>
<end position="700"/>
</location>
</feature>
<feature type="region of interest" description="JNK-binding domain (JBD)">
<location>
<begin position="127"/>
<end position="285"/>
</location>
</feature>
<feature type="region of interest" description="Minimal inhibitory domain (MID)">
<location>
<begin position="157"/>
<end position="176"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with MAP3K7" evidence="13">
<location>
<begin position="283"/>
<end position="471"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with VRK2" evidence="14">
<location>
<begin position="471"/>
<end position="660"/>
</location>
</feature>
<feature type="short sequence motif" description="D-box 1">
<location>
<begin position="353"/>
<end position="360"/>
</location>
</feature>
<feature type="short sequence motif" description="D-box 2">
<location>
<begin position="364"/>
<end position="372"/>
</location>
</feature>
<feature type="compositionally biased region" description="Asp/Glu-rich (acidic)">
<location>
<begin position="42"/>
<end position="48"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gly">
<location>
<begin position="79"/>
<end position="84"/>
</location>
</feature>
<feature type="compositionally biased region" description="Asp/Glu-rich (acidic)">
<location>
<begin position="107"/>
<end position="116"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Glu">
<location>
<begin position="331"/>
<end position="334"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="359"/>
<end position="363"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="15"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="29"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="40"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by MAPK8, MAPK9 and MAPK10" evidence="11">
<location>
<position position="103"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="152"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="181"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="187"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="193"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="195"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="196"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by MAPK8, MAPK9 and MAPK10" evidence="11">
<location>
<position position="205"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="214"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="311"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="328"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="330"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="340"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="355"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="366"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="369"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="407"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="409"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="12">
<location>
<position position="411"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="444"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="447"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="12">
<location>
<position position="448"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="469"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="471"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="472"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="473"/>
</location>
</feature>
<feature type="sequence variant" description="In NIDDM; dbSNP:rs119489103." id="VAR_012243" evidence="7">
<original>S</original>
<variation>N</variation>
<location>
<position position="59"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34420676." id="VAR_049664">
<original>A</original>
<variation>V</variation>
<location>
<position position="322"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs12295161." id="VAR_049665">
<original>R</original>
<variation>Q</variation>
<location>
<position position="353"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes MAPK9 interaction." evidence="11">
<original>R</original>
<variation>G</variation>
<location>
<position position="160"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes MAPK9 interaction." evidence="11">
<original>P</original>
<variation>G</variation>
<location>
<position position="161"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on KNS2 binding." evidence="8">
<original>P</original>
<variation>A</variation>
<location>
<position position="704"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes KNS2 binding." evidence="8">
<original>Y</original>
<variation>A</variation>
<location>
<position position="709"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9R237"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9WVI9"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00148"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00192"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10574993"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10700186"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11238452"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11726277"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11912189"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12756254"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16195223"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17709393"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18286207"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000305"/>
<sequence length="711" mass="77524" checksum="55EA53B30080A751" modified="2000-05-01" version="1">MAERESGGLGGGAASPPAASPFLGLHIASPPNFRLTHDISLEEFEDEDLSEITDECGISLQCKDTLSLRPPRAGLLSAGGGGAGSRLQAEMLQMDLIDATGDTPGAEDDEEDDDEERAARRPGAGPPKAESGQEPASRGQGQSQGQSQGPGSGDTYRPKRPTTLNLFPQVPRSQDTLNNNSLGKKHSWQDRVSRSSSPLKTGEQTPPHEHICLSDELPPQSGPAPTTDRGTSTDSPCRRSTATQMAPPGGPPAAPPGGRGHSHRDRIHYQADVRLEATEEIYLTPVQRPPDAAEPTSAFLPPTESRMSVSSDPDPAAYPSTAGRPHPSISEEEEGFDCLSSPERAEPPGGGWRGSLGEPPPPPRASLSSDTSALSYDSVKYTLVVDEHAQLELVSLRPCFGDYSDESDSATVYDNCASVSSPYESAIGEEYEEAPRPQPPACLSEDSTPDEPDVHFSKKFLNVFMSGRSRSSSAESFGLFSCIINGEEQEQTHRAIFRFVPRHEDELELEVDDPLLVELQAEDYWYEAYNMRTGARGVFPAYYAIEVTKEPEHMAALAKNSDWVDQFRVKFLGSVQVPYHKGNDVLCAAMQKIATTRRLTVHFNPPSSCVLEISVRGVKIGVKADDSQEAKGNKCSHFFQLKNISFCGYHPKNNKYFGFITKHPADHRFACHVFVSEDSTKALAESVGRAFQQFYKQFVEYTCPTEDIYLE</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

